← Back to Search

Other

Minimally-Invasive Procedure for Cancer

Phase 2
Waitlist Available
Led By Kaitlyn Kelly, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Eastern Cooperative Oncology Group (ECOG) (Zubrod) performance status of 0-2.
Aged > 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days of surgery
Awards & highlights

Study Summary

This trial is testing a new surgical technique that minimizes entry into the body and involves putting high concentrations of anticancer drugs directly into the abdomen. The goal is to improve short-term postoperative outcomes.

Eligible Conditions
  • Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days of surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days of surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of postoperative complications

Trial Design

1Treatment groups
Experimental Treatment
Group I: Minimally-Invasive ProcedureExperimental Treatment1 Intervention
single-arm study of laparoscopic cytoreduction and HIPEC
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Minimally-Invasive Procedure
2014
Completed Phase 2
~20

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,113 Previous Clinical Trials
1,519,852 Total Patients Enrolled
Kaitlyn Kelly, MDPrincipal InvestigatorUniversity of California, San Diego
1 Previous Clinical Trials
5 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025